P3 Health Partners Inc. PIII

Healthcare SIC 8000 - Services-Health Services NAICS Health Care and Social Assistance derived Nasdaq

We were incorporated in Delaware as Foresight Acquisition Corp. ("Foresight") on August 20, 2020. On December 3, 2021 (the "Closing Date"), we completed the Business Combinations (defined and discussed more fully below) with P3 Health Group Holdings, LLC, a Delaware limited liability company ("P3 Health Group Holdings") and we changed our name to P3 Health Partners Inc. Following the Business Combinations, we are organized in an "Up-C" structure, in which P3 Health Partners Inc. is the sole manager of P3 Health Group, LLC and directly owns approximately 46% of P3 Health Group, LLC as of December 31, 2025. Substantially all of the Company's assets are held and operations are conducted by P3 LLC and its subsidiaries, and the Company's only assets are equity interests in P3 LLC.

Last close 4.14 2026-10-23
Market cap $13.9M estimated share count
52-week range 1.52 - 16.89

Valuation FY2025 figures against the last close

P/S0.0x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-45.26

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $1.46B$1.50B$1.27B$1.05B$578.6M$491.1M$145.5M—
SG&A $106.3M$112.6M$122.4M$157.3M$22.7M$53.4M$36.4M—
Total operating expenses $1.73B$1.82B$1.43B$2.61B$707.7M$519.7M$185.0M—
Operating income -$270.3M-$320.7M-$167.9M-$1.56B-$22.7M-$28.6M-$39.5M—
Interest expense $55.0M$22.2M$16.0M$11.4M$9.8M$2.5M$2.5M—
Pre-tax income -$321.1M-$306.0M-$183.7M-$1.56B-$146.4M-$31.4M-$42.0M—
Income tax $2.0M$4.4M$2.7M$1.9M$0$0$0—
Net income -$323.1M-$310.4M-$186.4M-$270.1M-$24.8M-$31.4M-$42.0M—
EPS, basic -45.26-46.78-0.61-6.50————
EPS, diluted -45.26-54.06-0.63-6.50————
Shares, diluted (wtd. avg.) 3.3M2.9M294.6M41.6M————

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $25.0M$38.8M$40.9M$18.5M$140.8M$39.9M$32.6M$1.4M
Total current assets $133.1M$184.1M$166.0M$100.7M$199.9M$90.9M——
Property, plant and equipment $3.4M$5.7M$8.7M$8.8M$8.0M$6.2M——
Goodwill ———$0$1.31B$871.1K$741.1K—
Other intangibles $492.4M$574.4M$666.7M$751.0M$835.8M———
Total assets $656.6M$783.4M$861.0M$876.6M$2.36B$106.4M——
Accounts payable $11.7M$8.4M$8.7M$11.5M$5.5M$11.8M——
Short-term debt $45.0M$75.2M$0—$46.0K$90.0K——
Total current liabilities $545.3M$496.4M$299.4M$241.7M$198.8M$90.6M——
Long-term debt $228.4M$108.9M$108.3M$94.4M$80.0M$45.4M——
Total liabilities $796.9M$633.9M$427.3M$353.9M$299.9M$146.0M——
Retained earnings -$651.1M-$503.2M-$367.3M-$309.5M-$39.4M-$130.5M——
Total equity -$155.2M$75.9M$142.1M$5.9M$273.6M———

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow -$91.2M-$110.1M-$76.0M-$126.0M-$1.6M-$24.6M-$28.3M—
Depreciation and amortisation $2.2M$2.4M$2.3M$2.4M$1.5M$795.2K$399.2K—
Stock-based compensation $5.6M$5.8M$6.0M$19.4M$3.7M$447.5K$474.0K—
Capital expenditure —$0$1.8M$2.2M$3.3M$2.9M$1.5M—
Investing cash flow $129.0K$14.5M-$1.8M-$7.7M-$316.2M-$3.2M-$3.9M—
Financing cash flow $72.8M$98.8M$100.3M$11.4M$317.8M$34.8M$63.6M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001140361-26-018240.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B 1.5B 2B Revenue, FY2019: 145.5M Net income, FY2019: -42M Revenue, FY2020: 491.1M Net income, FY2020: -31.4M Revenue, FY2021: 578.6M Net income, FY2021: -24.8M Revenue, FY2022: 1B Net income, FY2022: -270.1M Revenue, FY2023: 1.3B Net income, FY2023: -186.4M Revenue, FY2024: 1.5B Net income, FY2024: -310.4M Revenue, FY2025: 1.5B Net income, FY2025: -323.1M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $145.5M $491.1M $578.6M $1.05B $1.27B $1.50B $1.46B
Gross profit — — — — — — — —
Net income — -$42.0M -$31.4M -$24.8M -$270.1M -$186.4M -$310.4M -$323.1M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
  • Delisting notice Item 3.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Material agreement signed Item 1.01
  • Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8000

TickerCompanyMarket capP/ERevenue growth
LFST LifeStance Health Group, Inc. $4.94B — 13.9%
PRVA Privia Health Group, Inc. $2.86B 124.5x 22.3%
WGS GeneDx Holdings Corp. $1.67B — 40.0%
PNTG Pennant Group, Inc. $1.46B 49.9x 36.3%
USPH U S PHYSICAL THERAPY INC /NV $1.32B 62.3x 16.3%
INNV InnovAge Holding Corp. $1.30B — 11.8%
OMDA Omada Health, Inc. $1.16B — 53.2%
SRTA Strata Critical Medical, Inc. $412.3M 9.3x 34.3%